新闻Aytu Consumer Health, Inc. partners with Neostx.Aytu BioScience (NASDAQ: AYTU ) announces the closing of its $44.9M merger with Neos Therapeutics, with Neos merging with a wholly-owned subsidiary of Aytu.
新闻Neostx has issues with violated the federal securities laws.Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Neos Therapeutics, Inc. (NASDAQ: NEOS) breached their fiduciary duties or violated the federal securities laws in connection with the company’s acquisition by Aytu BioScience, Inc. (NASDAQ: AYTU).
新闻Neostx has issues with possible breaches of fiduciary duty and other violations of law.WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Neos Therapeutics, Inc. ("NEOS" or the "Company") (NASDAQ: NEOS ) in connection with the proposed acquisition of the Company by Aytu BioScience, Inc. ("Aytu") (NASDAQ: AYTU ).
